You've likely seen commercials about new medications for previously hard-to-treat cancers populated with happy, disease-free people. And while direct-to-patient marketing for cancer does serve to educate, it often creates unrealistic expectations, says Dr. Ronald Natale, a medical oncologist at Cedars-Sinai in Los Angeles. These immunotherapy medications can be game-changing for some, but they don't work for everyoneand your care team will be able to determine what works best for your particular case.
The Downside of Direct-to-Consumer Marketing of Cancer Drugs
Fact Checked
/ Updated June 29th, 2018SurvivorNet Fact Checking and Medical Review Standards:
The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.
All SurvivorNet articles adhere to the following standards:
- All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
- When we use data, statistics, or quotes these references link to the original source.
- All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
- All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
- We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
The Downside of Direct-to-Consumer Marketing of Cancer Drugs
FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer
Famous TV Star, 49, Makes TV Incredible Return Despite Battling Chest Infection and Advanced Lung Cancer
Olympian Santiago Lange, 61, Who Beat Lung Cancer To Retire
The Anatomy of a Lung Cancer
Study Shares Hopeful New Lung Cancer Statistics
Rules For Living With Cancer